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Mechanically oriented bilayerWild-type phospholamban (WT-PLB) is a pentameric transmembrane protein that regulates the cardiac cycle
(contraction and relaxation). From a physiological prospective, unphosphorylated WT-PLB inhibits
sarcoplasmic reticulum ATPase activity; whereas, its phosphorylated form relieves the inhibition in a
mechanism that is not completely understood. In this study, site-speciﬁcally 15N-Ala-11- and 15N-Leu-7-
labeledWT-PLB and the corresponding phosphorylated forms (P-PLB)were incorporated into 1,2-dioleoyl-sn-
glycero-3-phosphocholine/2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPC/DOPE) mechanically or-
iented lipid bilayers. The aligned 15N-labeled Ala-11 and Leu-7 WT-PLB samples show 15N resonance peaks at
approximately 71 ppm and 75 ppm, respectively, while the corresponding phosphorylated forms P-PLB show
15N peaks at 92 ppm and 99 ppm, respectively. These 15N chemical shift changes upon phosphorylation are
signiﬁcant and in agreement with previous reports, which indicate that phosphorylation of WT-PLB at Ser-16
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Wild-type phospholamban (WT-PLB, 52 amino acid transmem-
brane protein) plays a major role in the regulation process of the
cardiac cycle (contraction and relaxation), which controls the
heartbeat [1]. Using 2H ss-NMR spectroscopy, it has been reported
that WT-PLB forms a pentamer in phosphatidylcholine (PC) mem-
branes [2]. From a physiological prospective, unphosphorylated WT-
PLB inhibits sarcoplasmic reticulumATPase activity and this inhibition
can be relieved (i.e. reestablishes Ca2+ ﬂow) by the cyclic AMP- and
calmodulin-dependent phosphorylation of WT-PLB [1]. Since WT-PLB
plays a major physiological role, several theoretical and biophysical
experimental studies have been conducted to probe its structure and
dynamics embedded into a membrane [3–34].
Early structural studies on WT-PLB disagreed on whether the
pentameric form of the protein is composed of ﬁve continuousα-helical
subunits or subunits that have two α-helices connected by an
unstructured/β-sheet region [3,4]. A solution NMR structural study bythe Chou group indicated that pentameric WT-PLB forms a bellﬂower-
like structural assembly in micelles, in which the α-helical cytoplasmic
domain of the pentamer on average points away from the membrane
surface [8]. Conversely, the Thomas group has indicated that the
cytoplasmic domain of each subunit of the WT-PLB is in direct contact
with the membrane surface forming an L-shaped pinwheel geometry
using ﬂuorescence resonance energy transfer (FRET) [5]. Clearly, the
structural topology of pentameric WT-PLB and its interaction with the
membrane have been under serious debate. Two recent structural
studies onWT-PLB from theLorigan [35] and theVeglia and Thomas [36]
labs have been conducted independently and both reports conclude that
the cytoplasmic domain of each subunit of WT-PLB is in direct contact
with themembrane surface forming an L-shaped pinwheel geometry in
POPC/POPEmembranes. In agreementwith thismodel, twoearlierNMR
studies suggested that a direct interaction takes place between the
cytoplasmic domain of the full-length WT-PLB and the phospholipid
head groups of the bilayers [6,7].
Similarly, another debate has been reported on the physiologically
active monomeric AFA-PLB mutant (AFA-PLB), in which all three
native transmembrane (TM) cysteines have been replaced byA36, F41,
and A46. The Veglia [9,10] and Baldus [37] groups, respectively,
disagree whether themonomeric AFA-PLBmutant structure has anα-
helical cytosolic segment that lies on and interacts with themembrane
surface (L-shaped structure) or a non-α-helical disordered cytosolic
domain that has minimal interactionwith the DOPC/DOPEmembrane
surface. Also, the effect of phosphorylation on the structural topology
of the cytoplasmic domain of the monomeric AFA-PLB mutant has
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group indicated that phosphorylation of Ser-16 (located within the
cytoplasmic domain) induces an order-to-disorder transition that
disrupts the “L-shaped” AFA-PLB monomer and causes a reduction in
the α-helical secondary structure around the phosphorylation site
[38]. This ﬁnding contradicts the research by Bigelow et al. which
suggested that phosphorylation of AFA-PLB increases the stabilization
of the helical content, especially in the hinge region, leaving the
cytoplasmic domain associated with the membrane [39].
In the case of pentameric WT-PLB, the effect of phosphorylation
on the structural topology of the cytoplasmic domain is not well
understood. Articles describing changes in the dynamics and structural
topology of the cytoplasmic domain upon phosphorylation in the
presence and/or absence of SERCA have resulted in different models
describing the interaction of PLB with SERCA [1,8,40].
In a recent study, we showed using 13C cross-polarization magic
angle spinning (CP-MAS) solid-state NMR (ss-NMR) experiments that
Ala-15 (closest to the phosphorylation site) representing the cytoplas-
mic domain is part of an α-helical structure with and without Ser-16
phosphorylation [6]. In another study, 2H and 15N ss-NMR spectroscopic
techniques were used to investigate both the side chain and backbone
dynamics of wild-type phospholamban (WT-PLB) and its phosphory-
lated form (P-PLB) incorporated into 1-palmitoyl-2-oleoyl-sn-glycer-
ophosphocholine (POPC) phospholipid multilamellar vesicles (MLVs)
[41]. Additionally, we used 15N ss-NMR spectroscopy to ascertain direct
information regarding the structural topology of the site-speciﬁc 15N-
labeled WT-PLB pentamer in oriented phospholipid bilayers, and the
alignment of each helix with respect to the bilayer normal has been
determined [35]. In this report,weextendandcomplementourprevious
dynamic and structural studies using 15N and 31P ss-NMR spectroscopy
on site-speciﬁcally 15N-labeled WT-PLB and P-PLB (phosphorylated at
Ser-16) embedded into oriented phospholipid bilayers.
2. Materials and methods
2.1. Materials
All synthetic phospholipidswere purchased fromAvanti Polar Lipids
(Alabaster, AL). The phospholipids were dissolved in chloroform and
stored at−20 °Cbeforeuse. Triﬂuoroethanol (TFE),N-[2-hydroxyethyl]
piperazine-N′-2-ethane sulfonic acid (HEPES) and acrylamide were
obtained from Sigma-Aldrich (St. Louis, MO). Fmoc amino acids,
prephosphorylated Ser Fmocderivative, and other chemicals for peptide
synthesis were purchased from Novabiochem (San Diego, CA). 15N-
L-Ala N-Fmoc derivative, 15N-L-Leu N-Fmoc derivative, 15NH4Cl, and
deuterium-depleted water were purchased from IsotecTM/Sigma-
Aldrich (Miamisburg, OH). Precise™ protein pre-cast gels and protein
standards for sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) were purchased from Thermo Scientiﬁc (Rockford, IL)
and Invitrogen (Carlsbad, CA), respectively.
2.2. Synthesis, puriﬁcation and characterization of 15N-labeled WT-PLB
and P-PLB
The peptides were 15N-labeled at the Ala-11 or Leu-7 positions,
synthesized using a modiﬁed Fmoc-based solid-phase synthesis
method and puriﬁed with preparative HPLC using a reverse phase
polymer column as reported previously [6]. The uniformly 15N-labeled
WT-PLB was over-expressed and puriﬁed as described previously
[42] with a slightly modiﬁed procedure as reported earlier [41]. The
proteins were lyophilized and characterized by matrix-assisted laser
desorption ionization time-of-ﬂight (MALDI-TOF) mass spectrometry
and SDS-PAGE. SDS-PAGE of WT-PLB and P-PLB were conducted
according to Wegener and Jones [47] using a 4 to 15% acrylamide
gradient in the resolving gel. After electrophoresis, the gel was stained
for 30 min with Coomassie Blue followed by overnight destaining.2.3. NMR sample preparation
For 15N NMR experiments, mechanically aligned samples contain-
ing site-speciﬁcally 15N-labeled WT-PLB or P-PLB in a mixture of 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE) lipids (4:1 ratio) were
prepared as described previously [44]. Brieﬂy, about 4–5 mg of 15N-
labeled peptidewas ﬁrst dissolved in aminimal amount of TFE prior to
cosolubilizing with 60 mg of the DOPC/DOPE lipids (peptide: lipid at a
1:100 mol ratio). The volume of the solution was reduced under a
stream of nitrogen gas to about 1 mL before any lipid or peptide
precipitated. The solution was separated onto 35 (5.7×12 mm) glass
plates and allowed to air-dry for 30 min before vacuum drying
overnight. Deuterium-depleted water was added onto the peptide/
lipid mixture (4 µL/plate), and the glass plates were stacked carefully
on top of each other. The stacked glass plates were then placed in a
humidity chamber consisting of saturated ammonium mono phos-
phate at a relative humidity of about 93% at 42 °C for 12 h. The glass
plates were then placed into a rectangular thin-wall glass cell with
one-pre-sealed end and the sample cell was sealed with wax before
placing it into the sample NMR coil.
The DOPC/DOPE lipid combination has been used for functional
reconstitution ofWT-PLB into lipidmembranes as determined by Ca2+-
ATPase activity [45]. The aligned samples were ﬁrst used in the 31P
ss-NMR experiments to evaluate the alignment of the lipid bilayers.
2.4. Solid-state NMR spectroscopy
A Bruker AVANCE 500 MHz (11.7 T) wide-bore NMR spectrometer
(Bruker, Billerica, MA) and a ﬂat coil 1H-X Low-E NMR probe (NMR
Instruments Development Group, NHMFL, Tallahassee, FL) with coil
dimensions 7.6×5.6×11 mm were used to collect the static 15N CP
and 31P NMR spectra [46].
The 31P NMR spectra were recorded with 1H decoupling using a
4.0 μs 90° pulse for 31P and a 4.0 s recycle delay. The spectral width
was set to 250 ppm. For the 31P NMR spectra 128 scans were taken
and the free induction delay was processed using 100 Hz of line
broadening. All 31P NMR spectra were referenced by assigning the 85%
H3PO4 31P peak to 0 ppm.
Static15N ss-NMR spectra were collected utilizing a RAMP cross-
polarization pulse sequence with 1H decoupling. The following pulse
sequence parameters were used: 5.0 μs 1H 90° pulse, 1.5 ms contact
time, 500 ppm sweepwidth, a 4.0 s recycle delay, and a proton B1 ﬁeld
strength of ∼50 kHz. Also, 120 K scans were averaged for the static
15N CP experiments and the free induction delay was processed using
300 Hz of line broadening. The 15N CP NMR spectrawere referenced to
an external standard of (15NH4)2SO4 (27 ppm).
For all the aligned samples, the radiofrequency (RF) coil was
adjusted so that the lipid bilayer normal was aligned parallel with the
static magnetic ﬁeld B0. All the ss-NMR experiments were conducted
at 25 °C.
3. Results
3.1. Electrophoresis analysis of PLB phosphorylation
The oligomeric states of both WT-PLB and P-PLB were examined
using SDS-polyacrylamide gel electrophoresis in Fig. 1. Both WT-PLB
and P-PLB are predominantly in the pentameric state on SDS-PAGE
gels, and do not show the coexistence of any signiﬁcant amounts of
monomeric or dimeric forms as reported for the monomeric forms
(AFA-PLB) [25,43]. The gel matches very well with previous studies
carried out by the Jones [47] and Thomas groups [48], in which P-PLB
migrates slower than WT-PLB due to decreased mobility. The shifted
P-PLB band shows up at a higher apparent molecular weight, upon
comparison with the WT-PLB band.
Fig. 1. SDS-PAGE gels of WT-PLB and P-PLB. From left to right: P-PLB, WT-PLB, and the
molecular weight marker.
Fig. 2. 31P solid-state NMR spectra of aligned DOPC/DOPE (4:1 ratio) bilayers in the
presence of 0 mol% (A), 1 mol% of 15N-uniformly-labeled PLB (B), 15N-Ala-11 labeled
WT-PLB (C) and P-PLB (E), 15N-Leu-7 labeled WT-PLB (D) and P-PLB (F), respectively.
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ylation in both detergent and lipid bilayers [48]. The Smith group [2]
has demonstrated with ss-NMR spectroscopy that the full-lengthWT-
PLB forms a pentamer in PC membranes and a similar conclusion was
reported in our previous transmembrane PLB (TM-PLB) studies [44].
Recent NMR studies have also suggested that a phosphorylation-
mimicking mutation does not perturb the pentameric structure of PLB
in DPC micelles [49].
3.2. The alignment of PLB in DOPC/DOPE bilayers
Fig. 2 shows the 31P NMR spectra of mechanically aligned DOPC/
DOPE (4:1 ratio) bilayers in the absence and presence of 1 mol% WT-
PLB and P-PLB. The results indicate that uniformly alignedDOPC/DOPE
lipid bilayerswith 31P resonance peaks at∼26 ppmwere formed in the
presence and absence of 1 mol% peptide. Thewell-resolved 31P peak at
∼26 ppm indicates that the phospholipid bilayers are well aligned
such that the bilayer normal is parallel with the static magnetic ﬁeld.
The linewidths at half height of the 31P NMR resonances are less than
1 ppm for the pure lipids and about 2.5 ppm for lipids containing 1 mol
% peptide.
31P NMR is effective for evaluating the quality of macroscopic
membrane alignment. 15N NMR resonance peaks from amide proteins
are also a direct indicator of the protein alignment in the membranes
and necessary for assessing the quality of sample alignment. One-
dimensional 15N ss-NMR spectra of uniformly 15N-labeled proteins
can also be used to monitor and optimize alignment conditions. As
shown in Fig. 3A, the dip in the baseline at ∼147 ppm of the 15N NMR
spectrum of uniformly 15N-labeled WT-PLB in aligned DOPC/DOPE
(4:1) glass plates is indicative of a well-oriented membrane protein
sample, because no 15N powder pattern components of signiﬁcant
amount are observed [50].
3.3. 15N solid-state NMR of WT-PLB and P-PLB in aligned DOPC/DOPE
bilayers
The topological orientation and dynamics of PLB, especially the
cytoplasmic domain, is believed to play a crucial role in the regulation of
the Ca2+pumpSERCA, inwhich theworkingmechanism is still not fully
understood [1,3–10,37–40]. SS-NMR spectroscopy of macroscopically
aligned proteins provides an important method to determine the
orientation of proteins in membranes and has been extensively used in
NMR studies of membrane proteins [35,36,50,51,53,55–62]. In order to
probe the effect of phosphorylation on the structural topology of the
cytoplasmic domain of WT-PLB, site-speciﬁcally 15N-labeled amideresidues located on the cytoplasmic domain (Ala-11 and Leu-7) of WT-
PLB and P-PLB were prepared and incorporated into aligned DOPC/
DOPE bilayers respectively and analyzed via 15N ss-NMR spectroscopy.
Fig. 3 shows the one-dimensional static 15N ss-NMR spectra of
uniformly 15N-labeled WT-PLB as well as site-speciﬁcally 15N-labeled
WT-PLB (Ala-11 and Leu-7) and their corresponding phosphorylated
forms (P-PLB) embedded inside mechanically aligned DOPC/DOPE
(4:1) phospholipids using glass plates. As in agreement with other
studies, the uniformly 15N-labeled WT-PLB spectrum shows two
distinct components at ∼73 ppm and at ∼211 ppm (Fig. 3A). In a
recent study, we showed using site-speciﬁcally 15N-labeled amide
residues located on both the cytoplasmic domain (Ala-11) and the
transmembrane domain (Leu-42 and Leu-51) of WT-PLB that the
component at 211 ppm (near σ||) belongs to the transmembrane
domain (nearly parallel with B0), whereas the component at 73 ppm
(near σ⊥) corresponds to the cytoplasmic domain of WT-PLB which
lies on the membrane surface [35].
The 15N-labeled Ala-11 WT-PLB and P-PLB samples show 15N
resonance peaks at approximately 71 ppm and 92 ppm, respectively
(Fig. 3B and C). Similarly, 15N-labeled Leu-7 samples of WT-PLB and
P-PLB reveal 15N resonance peaks at about 75 ppm and 99 ppm,
respectively (Fig. 3D and E). The 15N resonances linewidths of the
aligned site-speciﬁcally 15N-labeled peptides are about 15 ppm, with
the broadest peak of 17.8 ppm for 15N-Leu-7 P-PLB. The 15N linewidths
for the aligned peptides in Fig. 3B–E are in the range of 15 to 20 ppm,
which were observed in many aligned peptides in lipid membranes
[51,62]. The 15N-labeled Ala-11 and Leu-7 resonance peaks of WT-PLB
are very close to the σ⊥ component (73 ppm) of the 15N CSA tensor of
the corresponding powder spectrum, indicating that these two residues
Fig. 3. 15N cross-polarization NMR spectra of uniformly 15N-labeled WT-PLB (A) as well
as site-speciﬁcally 15N-labeled WT-PLB at Ala-11 (B) or Leu-7 (D), and P-PLB at Ala-11
(C) or Leu-7 (E) in oriented DOPC/DOPE (4:1 ratio) lipid bilayers. The 15N NMR powder
spectra of WT-PLB (F) and P-PLB (G) in POPC MLVs are also presented.
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dicular to the bilayer normal (sitting on the bilayer surface). This data
agrees with previous NMR studies by the Veglia, Thomas, and Lorigan
research groups on AFA-PLB and WT-PLB [35,36].
4. Discussion
Interestingly, the aligned 15N resonance peaks of 15N-labeled Ala-
11 and Leu-7 of P-PLB are shifted downﬁeld by more than 20 ppmwhen compared to the residue peaks of the corresponding WT-PLB
samples (Fig. 3B–E). These 20 ppm shifts are signiﬁcant and may be
due to several different factors (a) the negative charge on the Ser-16
residue after phosphorylation, (b) signiﬁcant backbone dynamic
changes in WT-PLB upon phosphorylation, and (c) structural pertur-
bations induced by phosphorylation.
If the 20 ppm shifts were induced by the introduction of the
negative charge on Ser-16 upon phosphorylation, the 15N isotropic CP-
MAS and the corresponding 15N CSA values would also be altered. The
15N CP-MAS NMR spectra of 15N-labeled Ala-11 WT-PLB and P-PLB
both yield the same isotropic CSA value of approximately 121 ppm
(data not shown) [41]. Furthermore, as seen in Fig. 3F–G, the 15N static
powder pattern NMR spectra of both samples are fairly comparable
with the following CSA values:σ11 (58 ppmand 60 ppm),σ22 (76 ppm
and 73 ppm) and σ33 (230 ppm and 229 ppm) for WT-PLB and P-PLB,
respectively [41]. Thus, this shift is not caused by the phosphorylation
charge on Ser-16.
If the ∼20 ppm shifts observed in the aligned samples for the
dominant form of P-PLB were solely due to dynamic motion of the
cytoplasmic domain upon phosphorylation, the 15N CSA values of the
powder pattern spectrum would also decrease by approximately
20 ppm (σ33–σ11) as well. This phenomenon can be observed in the
literature, 15N NMR spectra of both oriented and unoriented peptides
show a reduced 15N CSA when compared with that of rigid proteins,
indicating that the peptide undergoes uniaxial rotation around the
bilayer normal with correlation times faster than 10−4 s [52]. However,
as indicated previously, the 15N powder pattern CSA width (σ33–σ11)
values of P-PLB do not change by∼20 ppm. The 15N CSA powder pattern
spectra of
15
N-labeled P-PLB and WT-PLB have two components
(Fig. 3F–G), which indicate a slight increase in backbone motion for
P-PLB over WT-PLB [41]. The width of the broad axial symmetric
dominant component is slightly smaller (σ33–σ11=3 ppm), when
compared toWT-PLB. The isotropic componentof P-PLB is slightly larger
when compared to WT-PLB [41]. It should be noted that the aligned
NMR spectra presented in this paper were prepared on glass plates,
whereas the unoriented “powder pattern” spectra were collected in
MLVs. If the∼20 ppm15N shiftweredue tobackbonedynamics fromthe
cytoplasmic domain alone, one would expect to observe even more
dynamic averaging of the CSA values in the MLV samples, because the
bilayers are more hydrated than the corresponding aligned glass plate
samples. These large
15
N shift dynamic differences are not observed in
the P-PLB samples. In summary, we do observe slight
15
N backbone
dynamic differences (∼3 ppm 15N shift) between P-PLB andWT-PLB but
not enough to account for ∼20 ppm 15N shift.
The 20 ppm
15
N shift observed in the P-PLB samples is most likely
due to structural perturbations induced by phosphorylation. The struc-
tural changes may consist of one or a combination of the following:
(a) secondary structural changes in the cytoplasmic domain of P-PLB,
(b) changes in theoligomeric structure of P-PLB, or (c) changes in the tilt
and/or rotation angles of the cytoplasmic helix upon phosphorylation.
Signiﬁcant changes in the secondary structural conformation upon
phosphorylation are not supported by previous ss-NMR data on the
cytoplasmic domain of P-PLB andWT-PLB at positions Ala-11 and Ala-
15 [6,41].
15
N CP-MAS isotropic values of 15N-labeled amide residues at
Ala-11 are consistent with anα-helical structure for bothWT-PLB and
P-PLB [41]. In another study,
13
C CP-MAS ss-NMR spectra indicate
that Ala-15 (closest to the phosphorylation site Ser-16) representing
the cytoplasmic domain is still a part of an α-helical structure after
phosphorylation at Ser-16 [6].
The introduction of a negatively-charged phosphate group at Ser-16
could alter the oligomerization state of PLB, promoting PLB pentamer
formation slightly in lipid bilayers [48]. As shown in Fig. 1, bothWT-PLB
and P-PLB are predominantly in the pentameric state.Weonly observe a
single
15
N peak for both Ala-11 and Leu-7 in the WT-PLB and P-PLB
samples. The 15N peaks observed most likely are from the dominant
pentameric form of the protein.
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membrane are constrained by their tertiary structure, oligomerization
state and/or interaction with the lipid bilayers [53]. The
15
N NMR
spectrum of the aligned 15N uniformly-labeled PLB in Fig. 3A indicates
that protein backbone dynamics are on the 104 Hz time scale of the
15
N
amide chemical shift interaction [50]. Rotation about the peptide
long axis is almost static on the NMR time scale of 10−4 s [54]. Based
upon
15
N ss-NMR studies of peptides aligned almost parallel with the
membrane surface, rotation alone is unlikely to cause the
15
N resonance
peaks to shift from ∼70 ppm to 90–100 ppm [55–59]. Previous studies
by the Veglia group have shown that the cytoplasmic segment of the
dominantpentameric formofWT-PLB lays on the surfaceofDOPC/DOPE
membranes [36]. In that paper, the
15
N resonance peaks for the aligned
cytoplasmic domain ofWT-PLB range from approximately 65 to 82 ppm
[36]. The 15Npeaks presented in this paper for Ala-11 (71 ppm) and Leu-
7 (75 ppm) clearly fall into the range observed forWT-PLB by the Veglia
group. If upon phosphorylation, the cytoplasmic domain rotated about
the surface of the bilayer onewould expect the 15N values to potentially
change, but still vary between65 and 82 ppm. Clearly, the∼20 ppmshift
that we observe for the P-PLB samples falls outside the range observed
by the Veglia group for the cytoplasmic domain of WT-PLB.
One reasonable explanation for the ∼20 ppm 15N chemical shift
upon phosphorylation may be a helical tilt change in which the helical
orientation of P-PLB shifts away from the bilayer surface when
compared with WT-PLB. Based upon the 20 ppm 15N shift, the helix
would move about 15° from the surface of the bilayer [55]. Notably, the
membrane association of helix 2 of the HIV-1 viral protein U (Vpu) was
also shown to be weakened by phosphorylation using aligned ss-NMR
spectroscopic techniques [60]. As anticipated with this tilt, the 15N
chemical shift of 15N-Leu-7 is slightly larger than that of 15N-Ala-11,
because Leu-7 is closer to the end of the cytoplasmic helix than Ala-11.
The interpretation of this data ﬁts well with the allosteric activation
model of PLB by the Veglia and Thomas groups [40]. Furthermore, we
have shown using 31P NMR spectroscopy that WT-PLB and P-PLB
interact differently in MLVs [6]. In that study, P-PLB interacted less with
the phospholipid headgroups, when compared to WT-PLB. If the helix
of the cytoplasmic domain shifted away from the membrane surface,
one would expect less interaction with the phospholipid headgroups.
Thus, the lipid-protein interactions probed with 31P NMR agree with
the protein15N NMR results presented in this study. The 15N NMR
differences observed in this paper betweenWT-PLB and P-PLB aremost
likely due to either structural perturbations or a combination of
structural and slight dynamic backbone changes upon phosphorylation.
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